ALL Chemistry Inc. sell "ADCs Technology Services"

Antibody-drug conjugates (ADCs) are among the most promising new drug classes for cancers difficult to treat with conventional chemotherapy, seen as the next major advance in cancer therapy. ALL Chemistry Inc. offers state-of-the-art ADC technologies tailored to each customer's needs, delivering improved accuracy and reproducibility, reduced synthesis cost and time, greater control over reaction conditions, better scalability, and higher efficiency in synthesizing complex molecules.